ArticleAnnals of translational medicine2021

Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.

Keshu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.